Turkish Journal of Gastroenterology
Gastroenterology Elsewhere

Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies

1.

Division of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri, USA

Turk J Gastroenterol 2016; 27: 89-90
DOI: 10.5152/tjg.2015.150012
Read: 1148 Downloads: 544 Published: 25 July 2019
Files
EISSN 2148-5607